Clinical Trials Browser

Phase 3 × gilteritinib × 30 days × Clear all

NCT07407140 2026-03-25

VAG-3+7-G

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07463651 2026-03-20

TROPHY-15

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute